Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder Comorbidity

NCT01863459 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Adult Attention Deficit Hyperactivity Disorder (ADHD) With Co-occuring Anxiety and Depressive Disorders

Interventions

DRUG: Lisdexamfetamine Dimesylate
DRUG: placebo

Sponsor

Centre for Anxiety, Attention Deficit and Trauma, Ontario, Canada

Collaborators

[object Object]